Interestingly, another recent study (n = 7) discovered that HSP90 inhibition disrupted JAK-STAT signalling by potently decreasing JAK2 expression and the phosphorylation of STAT3 and STAT5 in patients with myeloproliferative neoplasms (40). This evidence concerns the gene HSP90AA1 and myeloproliferative neoplasm.